FundaMental Pharma
Latest round
- Seed
Last raised
- Sep 2022
Total raised
- $9.8M
Investors
- 4
About FundaMental Pharma
Founded in 2016 and headquartered in Heidelberg, Germany, FundaMental Pharma GmbH is engaged in the research and development of therapies for neurodegenerative diseases.FundaMental Pharma GmbH specializes in innovative therapeutic solutions aimed at combating neurodegenerative disorders. The company focuses on First-in-Class NMDAR/TRPM4 (N/T) Interface Inhibitors, which target the physiological functions of glutamate-gated NMDA receptors while mitigating their toxic effects associated with neurodegeneration. This mechanism preserves beneficial synaptic NMDA receptor functions on neuronal survival and memory, addressing conditions such as Alzheimer's disease.FundaMental Pharma generates revenue primarily through partnerships and collaborations with research institutions and pharmaceutical companies engaged in developing its therapeutic solutions. The revenue structure includes licensing agreements, milestone payments, and potential royalties from future sales of its NMDAR/TRPM4 (N/T) Interface Inhibitors, involving upfront payments and subsequent payments linked to specific development or regulatory milestones. The company aims to launch new products targeting neurodegenerative disorders and expand its market reach into additional regions over the next few years, specifically focusing on enhancing its presence in Europe and North America.
Who invested in FundaMental Pharma
4 investors across 2 rounds
See all investors in FundaMental Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about FundaMental Pharma
Who invested in FundaMental Pharma?
FundaMental Pharma has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has FundaMental Pharma raised?
FundaMental Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did FundaMental Pharma last raise money?
FundaMental Pharma's most recent round on record is a Seed, in Sep 2022.
What does FundaMental Pharma do?
Founded in 2016 and headquartered in Heidelberg, Germany, FundaMental Pharma GmbH is engaged in the research and development of therapies for neurodegenerative diseases.
Where is FundaMental Pharma headquartered?
FundaMental Pharma is headquartered in Heidelberg, Germany.
Which VCs invest in companies like FundaMental Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at FundaMental Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like FundaMental Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.